SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 1,025.09 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 284,229.00 |
| Book Value / Share | 1,455.67 |
| Price / Book | n/a |
| NCAV ($M) | 66,324.00 |
| NCAV / Share | 339.68 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.04 |
| Return on Assets (ROA) | 0.04 |
| Return on Equity (ROE) | 0.05 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.56 |
| Current Ratio | 2.38 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 240,709.00 |
| Assets | 458,614.00 |
| Liabilities | 174,385.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
Financial data and stock pages provided by
Fintel.io